Neurocutaneous Syndromes and Epilepsy

Autor: Aylin Bican Demir, Gülnihal Kutlu, Abidin Erdal, Yasemin Biçer Gömceli, İbrahim Bora, Ipek Midi, S. Naz Yeni
Přispěvatelé: MÜ, Erdal, Abidin, Demir, Aylin Bican, Midi, Ipek, Bicer Gomceli, Yasemin, Kutlu, Gulnihal, Yeni, S. Naz, Bora, Ibrahim
Jazyk: turečtina
Rok vydání: 2016
Předmět:
Popis: DEMIR, AYLIN BICAN/0000-0001-6739-8605; Yeni, S. Naz/0000-0001-7372-5430; E, A/0000-0003-3698-8201; WOS: 000408863600004 Objectives: Neurocutaneous syndromes are genetic diseases that affect the nervous system and the skin. Epileptic seizures are seen with variable frequency. In the present study, data of 29 patients from 5 centers were analyzed in an effort to draw attention to the disease group. Methods: Data of 29 patients diagnosed with neurocutaneous syndrome were retrospectively evaluated. Results: Study population was composed of 15 women (51.7%) and 14 men (48.3%), with a mean age of 31 (72 +/- 2.16). Ten patients (34.5%) were diagnosed with tuberous sclerosis, 9 (31%) with Sturge-Weber syndrome, 3 (10.3%) with neurofibromatosis type 1, 3 (10.3%) with neurofibromatosis type 2, 1 (3.4%) with neurocutaneous melanosis, 1 (3.4%) with hypomelanosis of Ito, 1 (3.4%) with probable Sturge-Weber syndrome, and 1 patient was diagnosed with unclassified neurocutaneous syndrome. One patient did not receive antiepileptic treatment, 9 (31%) received monotherapy, and 19 (65.5%) received polytherapy. Carbamazepine was the most commonly used medication. Conclusion: Attention is drawn to the prevalence of neurocutaneous syndrome in epileptic adults, with seizure frequency depending on syndrome type.
Databáze: OpenAIRE